THE story of Elan is so full of improbable twists that if you were to read about it in a novel, you would struggle to accept it as believable.

DURING 14 years of hard graft with Elan Donal Geaney played a key role in transforming it from a 32-person concern into a 24.5 billion international pharmaceutical company.